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Electroencephalographic derived 
network differences in Lewy body 
dementia compared to Alzheimer’s 
disease patients
Luis R. Peraza  1, Ruth Cromarty1, Xenia Kobeleva2, Michael J. Firbank  1, Alison Killen1, 
Sara Graziadio3, Alan J. Thomas1, John T. O’Brien1,4 & John-Paul Taylor1
Dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD) require differential management 
despite presenting with symptomatic overlap. Currently, there is a need of inexpensive DLB 
biomarkers which can be fulfilled by electroencephalography (EEG). In this regard, an established 
electrophysiological difference in DLB is a decrease of dominant frequency (DF)—the frequency with the 
highest signal power between 4 and 15 Hz. Here, we investigated network connectivity in EEG signals 
acquired from DLB patients, and whether these networks were able to differentiate DLB from healthy 
controls (HCs) and associated dementias. We analysed EEG recordings from old adults: HCs, AD, DLB 
and Parkinson’s disease dementia (PDD) patients. Brain networks were assessed with the minimum 
spanning tree (MST) within six EEG bands: delta, theta, high-theta, alpha, beta and DF. Patients 
showed lower alpha band connectivity and lower DF than HCs. DLB and PDD showed a randomised 
MST compared with HCs and AD in high-theta and alpha but not in DF. The MST randomisation in DLB 
and PDD reflects decreased brain efficiency as well as impaired neural synchronisation. However, the 
lack of network topology differences at the DF between all dementia groups and HCs may indicate a 
compensatory response of the brain to the neuropathology.
Dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD) are leading causes of neurodegenerative demen-
tia in older adults. DLB is characterised by the core symptoms of visual hallucinations, cognitive fluctuation and 
Parkinsonism. Other symptoms may also be present and precede the core ones such as autonomic dysfunction, falls, 
and sleep disturbances1. In contrast, patients with AD compared to DLB often have more significant memory prob-
lems; including memory loss, difficulty recalling recent events and learning new information2. At early stages both 
dementias present with an important symptomatic overlap3, e.g. problems with thinking and reasoning, leading to 
a frequent misdiagnosis of DLB patients as AD4. Another common cause of dementia linked to DLB is Parkinson’s 
disease dementia (PDD); this condition shares symptomatic and pathologic overlaps with DLB5. However their clin-
ical paths differ at the beginning of the disease; in DLB motor symptoms either occur concurrently with cognitive 
symptom onset or after, whereas PDD patients experience motor symptoms before the onset of cognitive decline1. 
AD and PDD offer two different disease perspectives for the understanding of DLB and this reflects the relative 
loading of pathology between the conditions, with DLB having both Alzheimer and alpha-synuclein pathology6.
Electroencephalography (EEG) represents an important neuroimaging modality to study the effects of demen-
tia in brain processes; previous work in the DLB field has been carried out by Bonanni, et al.7, Stam, et al.8 and 
Babiloni, et al.9 amongst others10–13, with the current consensus indicating that there is a slowing of the dominant 
frequency band (typically in the alpha frequency range) during eye-closed EEG at occipital regions in Lewy body 
dementia, and that this feature may be useful as a diagnostic biomarker of DLB versus AD14. The potential of this 
EEG feature as a DLB biomarker has been acknowledged as well by the recent consensus criteria for the clinical 
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diagnosis of this dementia15, where the slowing of the dominant band in patients has been given the status of sup-
portive biomarker to differentiate DLB from AD15. Compared with other neuroimaging modalities, EEG has the 
advantage of being non-invasive, widely available and inexpensive. Additionally, EEG can be acquired multiple 
times without associated side effects16.
The slowing of EEG frequencies in patients is commonly measured in quantitative EEG with the dominant 
frequency (DF). This DF is defined as the frequency with the highest power in the EEG spectrum7 and expected 
to be located between 4 and 15 Hz. In this regard, Bonanni, et al.17 showed a decrease of DF in DLB patients in 
occipital cortices compared with AD patients and healthy controls (HCs), and subtle differences when compared 
with PDD17. Additionally the authors also reported higher variability of DF in DLB patients which correlated with 
the level of cognitive fluctuations. Other proposed features which are gaining traction in dementia include that of 
brain networks18, which offer an integrative perspective for the complex functional connectivity of the brain and 
of particular interest is the subnetwork known as the minimum spanning tree (MST)19. A brain network is rep-
resented within the framework of graph theory by a graph comprised of nodes and edges20; in EEG the nodes are 
the electrodes and the edges are the connectivity between electrodes. Network connectivity can be estimated with 
the phase lag index (PLI), a connectivity measure resistant to the effects of the scalp’s volume conduction21. The 
MST is then the network which has the minimum number of strongest edges while connecting all nodes without 
cycling paths. Using this approach, Yu, et al.22 reported that in AD there exists a decentralisation of the network 
tree towards a line-like less efficient configuration. In the DLB field, van Dellen, et al.23 showed that patients pres-
ent with a decreased EEG network efficiency, which the authors linked to impaired cognition.
In this investigation we studied brain network connectivity in EEG recordings from DLB, AD, PDD, and HC 
participants in the sensor domain using the MST, in order to find network differences in DLB compared with the 
other associated dementias and HCs. In light of previous investigations on band power differences in DLB, we 
investigated MST topology at different canonical frequency bands including the DF band. We hypothesised that 
network topology features and their variability consistently differ among our studied dementia groups, that these 
may have potential use as differential biomarkers in DLB diagnosis versus AD and that these features would correlate 
with clinical cognitive and memory scores. In addition, we hypothesised that the functional network topology of 
our patient groups in the DF band would highlight pathological mechanisms of dementia and neural degeneration.
Results
After EEG pre-processing, 6 AD, 1 HC, 1 DLB and 1 PDD participants were excluded from the final analysis 
because their cleaned EEG recordings had less than 50 seconds of continuous EEG, resulting in final groups of 17 
HC, 26 AD, 25 DLB and 21 PDD participants.
Demographics. Demographics and clinical variables of our studied groups are given in Table 1. The recruited 
groups did not show significant differences in terms of age and gender. All patient groups were matched for global 
cognitive impairment by their CAMCOG and MMSE scores, although the AD group showed a trend of lower cogni-
tive impairment compared with the other dementia groups. The memory domain in the CAMCOG was significantly 
lower in the AD group than in PDD and DLB. Complex visual hallucinations (NPI hall) and cognitive fluctuations 
(CAF) were, as expected, higher in both Lewy body dementias compared to AD patients. In relation to their medi-
cations, PDD patients were on higher doses of dopaminergic therapy than the DLB group, but there were not signif-
icant differences between the dementia groups in terms of use of cholinesterase inhibitor medications.
Dominant frequency and network measures. The one-way ANOVA tests were significant for differ-
ences in DF across the four participant groups; F(85,3) = 6.75, p-value = 0.0004. Post-hoc tests showed that DLBs 
had a significantly lower DF (DLB: mean = 6.8 Hz, SD = 0.91) than ADs (mean = 7.5 Hz, SD = 1.21) and HCs 
(mean = 8.6 Hz, SD = 0.82) but not when compared against the PDD group (PDD: mean = 6.2 Hz, SD = 0.56). 
The AD group showed a lower DF than HCs but it was higher than in the PDD group, Fig. 1. The one-way 
ANOVA for the dominant frequency variability (DFV) also showed significant differences; F(85,3) = 4.59, 
p-value = 0.005. The AD group presented with significantly higher variability (AD: mean = 1.67 Hz, SD = 0.79) 
compared with the other groups, and DLBs showed significantly lower DFV (DLB: mean = 1.027 Hz, SD = 0.3) 
when compared with AD, Fig. 1.
The two-way four-group ANOVA tests (group and frequency band effects) for the network structure meas-
ures within the six frequency bands, showed significant differences for the maximum nodal degree (degreemax), 
leaf ratio, eccentricity, network diameter and radius (see Methods for a full description of MST measures); these 
measures were significant for the group effect. The global effects for these measures showed a decreased degree-
max and leaf ratio in the three dementia groups compared with HCs, predominantly in the alpha band, while 
diameter, eccentricity and radius were higher in the dementia groups compared with HCs, predominantly in the 
high-theta band and with a trend for differences in the means of HC < AD < DLB < PDD, see Fig. 2 upper row. 
However, when analysing the post-hoc between-group differences in network topology for the DF band, none of 
the post-hoc tests were significant, with uncorrected p-values > 0.05, Fig. 2 bottom row.
The MST-PLI related measures (PLI mean, leaf, root and height) were significant for both mean and variability 
but mainly for the interaction effect of group and frequency band—see Fig. 3. Differences between groups were 
found predominantly in the theta, high-theta and alpha bands. Specifically, the HC group was significantly differ-
ent when compared against the dementia groups for PLI measures in the alpha band. PLI height was significantly 
different between DLB and AD in the beta band.
Significant multiple linear regressions between the clinical variables and the network measures are shown 
in Table 2 and Fig. 4. None of the measures of variability related with the clinical variables, and we also tested 
these without the log-transformation with same results. For dominant frequency, the most significant relation 
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was found between it and verbal fluency in all dementia groups with a positive correlation, and in AD and DLB 
for the within-group correlations, see Table 2. Dominant frequency was also significantly related to animal nam-
ing, CAMCOG, MMSE and Trail A test, and showed a positive relation between DF and cognitive impairment 
by these clinical measures. PLI tree measures in the theta band significantly related to cognitive variables. The 
network mean PLI in the high-theta band significantly related to the frequency and severity of complex visual 
hallucinations (NPI hall) in the DLB group, see Fig. 4. We also tested whether changing the reference group in 
the multiple linear regressions altered the results, which it did not. Additionally, we tested if Levodopa presented 
with a significant effect on the EEG features for the DLB and PDD groups. No effect was found between Levodopa 
medication and significant network measures. However, there was a significant group effect as result of the higher 
Levodopa doses in the PDD group (Supplementary Table S7).
Diagnostic analysis. MST measures that showed significant differences for the diagnostic scenarios includ-
ing DF and DFV, were used in the classification analysis; the receiver operating characteristic curves for this anal-
ysis are shown in Fig. 5. AD vs DLB classification reached an 80% sensitivity (0.41–0.82 95% confidence internal 
CI), 85% specificity (0.42–0.92 CI) with 0.86 area under the curve (AUC). When differentiating DLB versus PDD, 
HC (N = 17) AD (N = 26) DLB (N = 25) PDD (N = 21) p-value
Age 76.18 ±5.65 76.46 ±7.83 75.8 ±6.5 73.29 ±5.842 F(3,85) = 1.03, p-value = 0.380Т
Male/Female 10/7 18/8 20/5 19/2 Χ
2(3, N = 89) = 5.89, 
p-value = 0.117ǂ
MMSE 29.12 ±0.857 20.08 ±4.279 22.64 ±4.3 22.71 ±4.85 F(2,69) = 2.81; p-value = 0.067*
CAMCOG total 96.47 ±3.69 66.54 ±16.46 76.08 ±12.92 73.38 ±13.88 F(2,69) = 2.89; p-value = 0.063*
CAMCOG executive 22.71 ±2.25 14.46 ±5.49 13.12 ±5.03 12.9 ±2.86 F(2,69) = 0.79; p-value = 0.457*
CAMCOG memory 23.47 ±2.035 10.88 ±5.1 18.04 ±4.9 17.48 ±5.05 F(2,69) = 15.5; p-value < 0.001*
CAMCOG attention 6.76 ±0.562 3.81 ±2.514 4.4 ±2.27 4.19 ±1.721 F(2,69) = 0.465; p-value = 0.63*
NPI hall 0 0 0.04 ±0.2 1.76 ±1.86 2.57 ±2.29 F(2,68) = 14.1; p-value < 0.001*
CAF total 0 0 0.6 ±1.52 3.92 ±4.142 6.63 ±4.271 t(42) = 2.12, p-value = 0.03╤
Animal Categorical 
fluency 20.71 ±5.71 11.15 ±5.25 11.16 ±3.88 11.33 ±4.14 F(2,69) = 0.011; p-value = 0.989*
UPDRS III 1.24 ±1.522 2.28 ±1.929 15.52 ±8.2 25.57 ±7.018 t(44) = 4.42, p-value < 0.001╤
Angle discrimination 19.63 ±0.88 18.24 ±3.72 16.17 ±4.85 16.55 ±4.99 H(2) = 4.1, p-value = 0.129ǂ
FAS Verbal fluency 45.12 ±16.53 25.96 ±16.14 19.68 ±12 20.81 ±13.7 H(2) = 1.94, p-value = 0.378ǂ
LEDD 0 0 0 0 164.88 ±231.6 818.23 ±381.3 t(44) = 7.15, p-value < 0.001╤
ACheI (yes/no) 0/17 24/2 23/2 16/4† Χ
2(2, N = 71) = 2.13, 
p-value = 0.346
Years since diagnosis 0 0 1.77 ±1.13 0.87 ±0.63 1.41 ±1.91 H(2) = 10.9, p-value = 0.004ǂ
Table 1. Demographics and clinical variables. *ANOVA three groups (AD, DLB, PDD); ТANOVA four groups; 
ǂχ2 test four groups. ǂUnpaired t-test (DLB vs PDD); ‡Kruskal-Wallis three groups (AD, DLB, PDD). †One PDD 
patient was on Memantine.
Figure 1. Dominant frequency (DF) and variability (DFV) box-plots. Four-group ANOVAs’ p-values are 
given for each test, uncorrected. DF mean and standard deviation (SD) per group: HC (8.59 Hz, SD = 0.82), 
AD (7.5 Hz, SD = 1.21), DLB (6.8 Hz, SD = 0.91), PDD (6.2 Hz, SD = 0.56). DFV mean and SD per group: HC 
(1.21 Hz, SD = 0.67), AD (1.67 Hz, SD = 0.79), DLB (1.027 Hz, SD = 0.3), PDD (1.048 Hz, SD = 0.42). Each box 
in the plots shows the median as the central line, the extremes of each box are the first and third quartile and the 
whiskers represent the minimum and maximum values in the sample. DF and DFV were estimated from the 
occipital electrodes; see Supplementary Fig. S1.
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sensitivity was 76% (0.27–0.83 CI) and specificity was also 76% (0.58–0.88 CI); 0.77 AUC. Classification between 
HC and AD + DLB reached 0.96% sensitivity (0.78–1.0 CI) and 77% specificity (0.58–0.90 CI), 0.93 AUC. The 
step-wise multiple linear regression showed that for the AD vs DLB separation, the DFV was the best discri-
minant between both dementias (p-value = 0.0083) followed by PLI height in the beta band (p-value = 0.027). 
When diagnosing both combined groups AD + DLB versus the HC group, the step wise linear regression 
showed that the best discriminants were the PLI leaf mean in the alpha band (p-value < 0.0001) followed by DF 
(p-value < 0.0039). For the classification between DLB and PDD the PLI mean in the alpha band was the best 
discriminant between both groups (p-value = 0.0012).
Discussion
Our analysis showed significant differences between the dementia groups and HCs for DF and PLI network meas-
ures. We confirmed the well-established finding that there is a slowing of DF in the Lewy body dementias—DLB 
and PDD—compared with AD and HCs in the occipital regions9,16,24,25. Additionally, we explored the variability 
of DF between the studied groups and we demonstrated that DFV is higher in AD compared with HCs and both 
Lewy body dementia groups. Differences between the MST measures were significant at several frequency bands; 
theta, high-theta and alpha. However, PLI height scores in the beta band were shown to be lower in DLB com-
pared with AD patients.
PLI height is a measure of focused synchronisation in the root node (high PLI values and degreemax) and to 
be higher requires the existence of leaves far away from the root with low PLI connections, these latter lower 
than the root node connections26. A decrease in PLI height will therefore occur in two scenarios: (1) a star-like 
topology where the majority of edges connecting the root and leaf nodes are the same or (2) a PLI random con-
nectivity matrix, where there are not significant differences in PLI strength between leaf edges and root edges. 
Our results suggests the latter case, i.e. that our DLB and PDD groups present with a randomisation of the MST. 
This is observed by the global effects of the network measures; the lower degreemax and leaf ratio in the alpha band 
combined with higher network diameter, eccentricity and radius in the high-theta band indicate network rando-
misation, and a decrease in global efficiency of the MST. Similar results were reported by Olde Dubbelink, et al.27 
and Utianski, et al.28 who showed than in PD and PDD respectively, there exists a less “star-like” network topol-
ogy or as Yu, et al.22 reported, a “line-like” topology in dementia patients. Specifically, Utianski, et al.28 reported 
decreased number of MST leaves in PD patients. A more line-like network topology suggests a desynchronization 
of neural communication, where the brain network of dementia patients fails to engage in focused regional syn-
chronisations which may happen at different locations depending on the brain’s dynamics. Visualisation of these 
MST network characteristics in four representative participants is shown in Fig. 6, for the alpha and DF bands. 
The star-like topology can be easily observed in the HC participant where two highly connected nodes comprise 
the centre of the star. The randomised tree or line-like topology can be observed easier in the DLB patient in the 
dominant frequency example (bottom row); nodes here are not highly connected (low degreemax) and several 
nodes are connected within the same path in a sequence, i.e. lines.
In a previous investigation, van Dellen, et al.23 reported a PLI decrease in the alpha band of DLB patients com-
pared to AD and HCs. This contrasts somewhat with our investigation where PLI alpha was not significantly dif-
ferent between AD and DLB, although we demonstrated that it was lower in both dementias when compared with 
HCs. Instead we found that there are PLI differences in the high-theta and beta band between AD and DLB. PLI 
Figure 2. Two-way four-group ANOVA tests for the group effect. Upper row: The most significant post-hoc 
one-way ANOVAs per network measure and frequency band are shown. Significant (at p-value < 0.05 for the 
multiple unpaired t-tests) post-hoc between-group differences for the group means are indicated with line 
markers in magenta colour. Bottom row: post-hoc one-way ANOVA tests for the dominant frequency (DF) per 
network measure were nonsignificant. *Post-hoc multiple unpaired t-tests for comparisons between participant 
groups were also nonsignificant for the DF band. †ANOVA p-values are shown uncorrected for multiple 
comparisons; multiply by 72 for Bonferroni adjustment. For each plot, the line crosses the group means and the 
error bars span the first and third quartiles. Group effects are given in Supplementary Table S1 and their mean 
in Supplementary Table S2.
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alpha band differences in our study occurred when comparing HCs against all dementia groups but not between 
the dementia groups. This suggests that PLI in the alpha band is a marker of healthy brain but that it is not specific 
enough to differentiate between dementias9.
Exploratory diagnostic classification between AD and DLB was achieved by MST-PLI measures in the 
high-theta and beta bands as well as DF and DFV with high sensitivity and specificity of 80% and 85% respec-
tively, and which is comparable to FP-CIT SPECT imaging29. For this classification analysis, the most significant 
discriminant was the larger DFV in the AD group followed by the lower PLI height in beta band in the DLB 
group. This contrasts with the results by Bonanni, et al.17 who reported higher DFV in DLB patients compared 
to AD ones and higher DFV than HCs for both dementia groups17. This result disagreement may be driven by 
cohort specific differences or by the estimating method for DFV; here DFV was defined as the standard devia-
tion of the DF throughout the EEG segments, while in Bonanni, et al.17 DFV was defined using a visual rating 
of DF range on sequential EEG segments. Previous investigations using EEG features have reported similar or 
higher classification rates when differentiating Lewy body dementias and AD groups. For instance, Garn, et al.30 
reported 100% accuracy separating AD from a group of DLB-PDD patients using 25 EEG features, and Snaedal, 
et al.31 reported an accuracy of 91% in a similar group set-up using 37 EEG features. It is difficult to compare the 
performance between these investigations and ours due to differences in adopted approaches (the latter focussed 
on canonical spatial-temporal EEG features compared to our work which additionally used graph theory derived 
metrics/features) and number of features used for classification (nine features in our investigation). Additionally, 
these two previous reports30,31 used a collated DLB-PDD group which may have biased the group classification as 
PDD patients may be closer to PD in the Lewy body spectrum5,32 and neuropathologically further away from AD 
in contrast to DLB. In this investigation, we decided to keep our PDD and DLB groups separated since there is a 
clinical interest on the correct diagnosis of DLB versus AD, but not so much between AD and PDD given PDD 
Figure 3. Minimum spanning tree measures that showed significant differences across the groups of interests; 
ANOVA tests’ p-values are shown Bonferroni adjusted, i.e. multiplied by a correction factor that accounts 
for the 72 post-hoc one-way ANOVA tests. Significant multiple unpaired t-tests, p-value < 0.05, within each 
one-way ANOVA test are shown with line markers (in magenta colour) for the two groups with different 
means. For each plot, the line crosses the group means and the error bars span the first and third quartiles; 
mean and standard deviation are given in Supplementary Table S4. Bottom-right: Minimum spanning tree 
example comprising nine nodes and eight edges, where five of them connect leaf nodes. A(i, j) is the network 
adjacency matrix where an edge between nodes i and j is indicated with 1, and 0 otherwise. PLI(i, j) is the PLI 
score between nodes i and j. M is the total number of electrode nodes. See Supplementary Table S3 for variable 
meaning.
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patients are diagnosed with PD prior to the onset of dementia33. Related to this, a recent report by Babiloni, et al.9 
showed a 69.7% accuracy differentiating AD from DLB (64.7% sensitivity, 73.8% specificity) using only three EEG 
features associated with occipital alpha and delta power. However, higher diagnostic classification can be achieved 
by combining neuroimaging modalities. For instance, Colloby, et al.13 reported 86% sensitivity and 93% specific-
ity (90% accuracy) classification for DLB versus AD, using a combined EEG-structural MRI approach. Forward 
projection of the MST-PLI and DF measures presented here, onto independent EEG samples will be required to 
clarify the robustness of these measures as diagnostic tools for DLB.
DF and MST-PLI frequency scores significantly related with cognitive variables in our patients, suggesting 
a pathological relation with dementia. The verbal fluency test, which measures executive function, was highly 
positively correlated with DF in the dementia groups. Complex visual hallucinations (severity and frequency) 
was related with PLI mean in high-theta band, and significantly correlated within the DLB group, see Table 2. To 
date, we are not aware of previous investigations reporting a relation between complex visual hallucinations and 
resting state EEG features in DLB; this core symptom is frequently studied with event related responses34,35 or 
transcranial stimulations36. However, previous EEG investigations in the Charles Bonnet syndrome (CBS) which 
is characterised by complex visual hallucinations in people with partial or severe blindness, have reported alter-
ations in alpha and theta power37,38 and this agrees with our results. Nevertheless, we must also take into account 
that our multiple linear regression results are uncorrected, and thus these findings must be taken with caution.
None of the MST measures were significantly different between groups for the individualised DF band in 
measures related to network structure such as diameter, radius and eccentricity; see Fig. 2 bottom row. This sug-
gests that in dementia, the EEG network which is present at lower dominant frequencies and whilst these domi-
nant frequencies are pathological, it is still a network which would have been present in the premorbid state with 
normal structural neural communications, and thus may represent a reactive or compensation state39. A recent 
EEG investigation on brain connectivity by Frantzidis et al.39 reported compensation in participants with mild 
cognitive impairment (MCI), a condition that often preludes the onset of AD. They demonstrated the presence 
of densely connected regions in the networks of MCI participants but not in healthy controls, which the authors 
attributed to a compensation mechanism at early disease stages. Brain compensation is a phenomenon reported 
as well in functional magnetic resonance imaging (fMRI) research40. In fMRI, compensation is expressed and 
interpreted as an over-recruitment of neural circuits in order to maintain cognitive levels or motor processes in 
the presence of disease. In this regard, computational models of cortical activity have proven that the resonance 
frequency—dominant frequency—of neural circuits is inversely proportional to the size of the excited tissue41, 
i.e. larger networks communicate at lower frequencies42. These investigations thus suggest that the decrease of 
dominant frequency observed in our Lewy body dementia and Alzheimer’s disease participants may be an effect 
of over-recruitment of neural tissue in order to maintain a dynamic network structure similar to healthy controls; 
or in other words, recruitment of larger neural circuits needed for compensation is implemented by the brain at 
lower frequencies. It is suggested that the slowing of DF is driven by neurodegeneration of the cholinergic system 
not only in parkinsonian diseases43 but also in AD44. Evidence for this comes from EEG investigations analysing 
the effect of cholinesterase inhibitors and the partial restoration of alpha band power after medication45,46. Our 
results then propose a complementary perspective of these previous findings for the relation between cholinergic 
dysfunction in dementia and DF slowing as a compensatory mechanism.
Network variable Clinical variable
Linear regression
[AD + DLB + PDD] HC AD DLB PDD
Β1 Β1 p-value ρ (p-value) ρ (p-value) ρ (p-value) ρ (p-value)
PLI high-theta mean NPI hallucinations −9.87 0.0463 — (–) 0.047 (0.824) −0.498 (0.011) −0.127 (0.584)
PLI theta mean Animal naming −31.47 0.0400 0.22 (0.398) −0.36 (0.075) −0.31 (0.129) 0.05 (0.842)
PLI theta mean CAMCOG memory −39.83 0.0204 −0.04 (0.866) −0.23 (0.261) −0.31 (0.137) −0.33 (0.147)
PLI theta mean CAMCOG total −119.70 0.0153 0.06 (0.834) −0.33 (0.105) −0.32 (0.116) −0.21 (0.361)
Leaf theta mean Animal naming −48.14 0.0221 0.02 (0.938) −0.43 (0.027) −0.32 (0.120) −0.02 (0.933)
Leaf theta mean CAMCOG memory −58.91 0.0125 0.19 (0.460) −0.31 (0.130) −0.28 (0.174) −0.36 (0.113)
Leaf theta mean CAMCOG total −169.77 0.0124 0.21 (0.430) −0.37 (0.061) −0.33 (0.110) −0.21 (0.373)
Root theta mean CAMCOG memory −43.24 0.0196 −0.03 (0.914) −0.17 (0.395) −0.29 (0.148) −0.43 (0.054)
Root theta mean CAMCOG total −126.38 0.0178 0.07 (0.788) −0.25 (0.220) −0.32 (0.124) −0.32 (0.161)
Dominant frequency Animal naming 1.36 0.0131 0.3 (0.244) 0.41 (0.040) 0.25 (0.230) 0.03 (0.902)
Dominant frequency CAMCOG attention 0.59 0.0317 −0.27 (0.292) 0.34 (0.088) 0.38 (0.062) −0.38 (0.091)
Dominant frequency CAMCOG executive 1.54 0.0071 0.22 (0.393) 0.38 (0.056) 0.32 (0.124) 0.02 (0.918)
Dominant frequency CAMCOG total 5.24 0.0029 0.08 (0.756) 0.5 (0.010) 0.33 (0.104) −0.05 (0.819)
Dominant frequency MMSE 1.19 0.0294 −0.25 (0.336) 0.45 (0.021) 0.30 (0.141) −0.2 (0.389)
Dominant frequency Trail A −21.88 0.0266 −0.28 (0.270) −0.42 (0.034) −0.27 (0.220) −0.39 (0.112)
Dominant frequency Verbal fluency 6.93 3.69E-05 0.20 (0.439) 0.59 (0.002) 0.52 (0.008) 0.16 (0.559)
Table 2. Multiple linear regressions controlling for group membership with two dichotomous variables (D) 
for the Lewy body dementia groups. Model: Clinical variable ~ β1*network variable + β2*DDLB + β2*DPDD. 
Shown p-values correspond to the β1 coefficient for the network variable in the regression model and are shown 
uncorrected. Within group Pearson’s correlation and p-values are also given; full model’s coefficients are given 
in Supplementary Table S5.
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Our investigation has some limitations. First, all patients were medicated at the time of assessment and poten-
tially on agents which are known to alter EEG and could, for example, partially restore alpha power in patients. 
Despite this, we were able to find robust differences between patients and healthy controls and our results were 
in agreement with previous work in the field. Also, eyes-open EEG was not investigated in the current report 
which may offer higher diagnostic ratios if combined with features from eye-closed EEG. We were also unable to 
test our studied network features for disease progression, since we do not have longitudinal patient data. Ideally, 
EEG biomarkers for DLB should be investigated in the prodromal phase of the disease when clinical diagnosis is 
uncertain47, and with follow-up patient assessments; certainly early and distinct EEG changes are evident in MCI 
patients who go on to develop dementia7. Finally, the MST approach followed in the current investigation does 
not provide regional measures of network connectivity which may offer as well other important features for diag-
nostic classification and disease progression27. Future research will be needed to investigate all these possibilities 
including external validation of biomarkers. This work represents a first step in biomarker discovery and further 
investigations to evaluate cost-effectiveness, increased patient benefits in comparison with the current diagnostic 
standard, and feasibility of introduction of such biomarkers in the current care pathway are needed before these 
indexes can be proposed as validated biomarkers.
Figure 4. Selected significant multiple liner regressions between clinical variables and network measures. 
*P-values for the β1 coefficient for network measure are shown uncorrected. Significant within group Pearson’s 
correlations, at p-value < 0.05, are shown with thicker dashed lines; see Table 2 for all significant results. Model: 
Clinical variable ~β1*network variable + β2*DDLB + β2*DPDD + Intercept, where D is a dichotomous vector for 
each of the Lewy body dementia groups.
Figure 5. Receiver operating characteristic (ROC) curves by logistic regression for each of the diagnostic 
scenarios analysed, see Supplementary Table S6. Magenta dashed lines show the 95% confidence intervals 
for the ROC curves; bootstrapping with 5000 iterations implemented with the perfcurve MATLAB function. 
Optimal sensitivity and specificity as well as the area under the curve (AUC) are shown within each curve plot.
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In conclusion, we found that the alpha band and its related MST network measures are markers of healthy 
brain as compared with dementia, while DLB and AD patients differentiated in DFV and PLI height in the beta 
band, and that these measures resulted of higher utility as potential diagnostic biomarkers. We demonstrated that 
DLB as well as PDD present with a randomised or line-like MST network compared to HCs, and this suggests a 
decrease in focused neuronal synchronisation in these patients for the high-theta and alpha bands. In contrast, we 
found potential evidence of compensation in the functional network within the dominant frequency band, where 
no differences were found between our dementia groups and healthy controls for the topology of their MSTs.
Methods
Participants and clinical assessments. A total of 98 old adult participants were recruited within the 
North East of England. Dementia patients were recruited from a population referred to old age psychiatry and 
neurology services: 32 patients with AD (22 male, 10 female), 26 patients with DLB (21 male, 5 female), and 22 
patients diagnosed with PDD (20 male, 2 female). Additionally, 18 healthy controls (HC) were recruited for group 
comparisons (11 male, 7 female). Patient groups were diagnosed by two experienced clinicians according to the 
clinical diagnosis criteria for these dementias: The dementia with Lewy bodies consensus criteria1,15, the diagnos-
tic criteria for PDD33, and the National Institute on Aging-Alzheimer’s Association criteria for AD48.
All participants underwent comprehensive neurological and neuropsychiatric examinations. Specific tests rel-
evant to the present study included the Mini-mental state examination (MMSE), the Cambridge cognitive battery 
tests (CAMCOG) as measures of global cognition as well as trail making test A, animal naming, FAS verbal fluency 
and visual perception (angle discrimination task). The latter tests, representative of executive and visuo-perceptual 
function, are often disproportionately affected in LBD and thus considered as key additional cognitive measures 
for correlation against our MST metrics. To assess whether MST alterations were associated with other core symp-
toms of LBD such as motor parkinsonism, cognitive fluctuations and visual hallucinations, the Unified Parkinson’s 
Disease rating scale part III (UPDRS III), cognitive assessment of fluctuations (CAF)49 scale, and the neuropsychiat-
ric inventory test subscale for the severity and frequency of hallucinations (NPI hallucinations) were assessed; for the 
latter, carers were specifically asked about visual hallucinations rather than hallucinations in other modalities50. For 
patients that were on dopaminergic therapy, the Levodopa equivalent daily dose (LEDD) was estimated51. A MMSE 
score <8 for patients and <26 for the HC group was used as exclusion criteria. None of the recruited healthy partici-
pants had a history of neurological or psychiatric conditions and neither did the patients outside their core dementia. 
Figure 6. EEG minimum spanning tree examples from representative participants. Each participant was 
chosen as representative for being the median of their respective groups according to the leaf ratio mean in 
the alpha band. Similarly, the dominant frequency tree is also shown for the same participants. Notice the 
distinguishable “star-like” topology for the alpha-band network tree of the healthy control (HC) with two nodes 
with high nodal degree, and the more random tree in Lewy body dementia patients with a “line-like” topology; 
dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD). The Alzheimer’s disease (AD) 
patient also shows a star-like topology, although not as evident as the HC, suggesting impaired network. At the 
top of each network tree, the same network is shown on an EEG 10-5 system layout; here the diameter of the 
EEG electrodes is proportional to their nodal degree.
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Patients with Parkinsonism and on dopaminergic therapy were studied in the “ON” state. Ethical approval for this 
study was given by the Northumberland Tyne and Wear NHS Trust and Newcastle University ethics committee, and 
all methods in this study followed approved research guidelines by the mentioned ethics committee. All participants 
gave written informed consent prior study participation.
Electroencephalography and signal processing. Resting EEG recordings were acquired with 
Waveguard caps (ANT Neuro, The Netherlands) comprising 128 sintered Ag/AgCl electrodes placed in a 10–5 
positioning system52. Channels were recorded with a sampling frequency of 1024 Hz and electrode impedance of 
<5 KΩ. At recording, all electrodes were referenced to Fz channel and the ground electrode was attached to the 
right clavicle. 150 seconds of continuous EEG resting state eyes closed were stored for off-line data processing, 
participants were seated throughout the recording and instructed to remain awake and as still as possible.
All pre-processing steps were carried out blinded to group membership and implemented with EEGLAB53 
MATLAB functions (R2012; MathWorks, Natick Massachusetts). 1) EEG channels had their baseline component 
subtracted and were band pass filtered between 0.3 Hz and 54 Hz with a second order Butterworth filter. 2) Bad chan-
nels were deleted including the reference electrode Fz; mean of four channels, with minimum one and maximums of 
10 channels deleted. 3) Independent component analysis (ICA) with the FastICA54 algorithm using default parame-
ters was run for the entire EEG recording and up to 12 artefactual independent components were deleted. At this step 
special interest was put on identifying eye blink, cardiac and the 50 Hz power line components, i.e. components that 
were noisy throughout the EEG recording. 4) If after component deletion artefactual components were still identified, 
FastICA algorithm was run again and up to 6 artefactual components were deleted. 5) Noisy EEG segments with 
artefacts affecting all channels (e.g. muscle artefacts) were deleted. 6) EEG components were remixed to the sensor 
domain. 7) Previously deleted bad channels were spatially interpolated with EEGLAB using spherical interpolation. 
8) As final step, the electrode montage was modified to average montage55. Participants with less than 50 seconds of 
continuous EEG after artefact cleaning were excluded from the remaining of the analysis. Curated and raw 50-second 
EEGs signals as well as anonymised clinical data are available upon request from the senior author (J-PT).
Dominant Frequency and its variability. Dominant frequency (DF) was estimated for the 50 second 
EEG segments. First, occipital channels (PO and O channels) were averaged to obtain a representative signal from 
this region, see Supplementary Fig. S1. Power spectral density was then estimated with Welch’s periodogram; 
2048 sample segments tapered with a Hamming window, 50% overlap between segments and a fast Fourier trans-
form size of 2^13; these parameters led to a frequency resolution of 0.125 Hz. We defined DF as the frequency 
bin in the power spectrum with highest power between 4 and 15 Hz. DF for each participant was then estimated 
as the mean dominant frequency across the 49 windowed segments and DF variability (DFV) was defined as the 
standard deviation (SD) across the segments.
Phase lag index. Phase lag index (PLI) was chosen to measure the regional relation among all electrode pairs56. 
Briefly, PLI uses the Hilbert transform to estimate consistent causal delay between two signal sources and it has been 
proven that this measure is less affected by the scalp’s volume conduction, a problem with other measures such as 
spectral coherence or Pearson’s correlation55. PLI scores are bounded between 0 and 1, where 0 means lack of causal 
synchronisation and 1 full causal synchronisation. In this investigation, PLI was estimated for six frequency bands: 
the standard EEG delta (0.5–4 Hz), theta (4–5.5 Hz), high-theta (5.5–8 Hz), alpha (8–13 Hz), beta (13–30 Hz) and the 
dominant frequency band (DF ± 2 Hz) whose centre was participant specific. Frequencies >30 Hz were not studied 
since these are particularly affected by muscle artifacts, eye movement and microsaccades57,58. To compute the PLI 
scores, the 50 second EEG recordings were first filtered at each of the defined frequency bands using a second order 
Butterworth band-pass filter, then Hilbert-transformed and finally segmented into two-second segments with one 
second overlap leading to a total of 49 segments. After this, 49 PLI connectivity matrices of dimension 128 × 128 
elements were computed for each two-second segment, frequency band and participant.
Minimum spanning tree. The minimum spanning tree (MST) in EEG networks is a subgraph which 
encompasses the strongest edges within the connectivity matrices, and reaches all nodes without creating cycling 
paths19. Here the edges of the network are represented by their connectivity strength given by the PLI scores and 
the nodes of the network are the electrodes. The Prim’s algorithm59 was used to estimate the MST with one minus 
the PLI score as input. Then, 10 MST measures and their variability (mean and SD; thus providing a total of 20 
measures) were estimated for each frequency and participant. These measures are:
Maximum betweenness centrality (BCmax). Is a measure of hubness or centrality60 and it is proportional to the 
number of shortest paths that crosses a node in the tree61. A node with high BC indicates high reachability of 
that node throughout the network. BCmax then represents the node with highest BC in the MST62, and decreased 
BCmax suggests that the MST has decreased global efficiency19.
Diameter. This is the largest distance or number of edges between any two nodes in the tree. An increased diam-
eter indicates decreased network efficiency28.
Eccentricity. Is the maximum distance or number of edges between a node and any other node in the tree. Here 
we summarised this measure as the average eccentricity across all nodes in the tree62. Increased eccentricity in the 
MST suggests decreased network efficiency.
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Radius. The smallest node eccentricity in the tree.
Maximum degree (degreemax). The degree of a node equals the number of edges connected to that node. The 
degreemax is the highest degree in the MST and belongs to the most connected node in the network62. This is a 
measure of focused synchronisation, and the highest possible degreemax score would correspond to a MST that has 
a “star” topology19 with only one central node connected.
Leaf ratio. The number of nodes connected to the MST by only one edge divided by the maximum number of 
possible leaves (M-1), where M equals 128 electrode nodes in this investigation.
PLI mean. The mean PLI score across the entire MST network.
PLI leaf. The mean PLI for all the edges connected to the leaf nodes.
PLI root. The mean PLI for the root node of the MST. Here the root is defined as node with the highest degree. 
Hence, PLI root is the mean PLI score for the edges connected to the node with highest degree in the MST.
PLI height. The difference between PLI root minus PLI leaf. PLI root equals the PLI leaf score if the MST has a 
star configuration19.
MST measures were computed using functions from the Brain Connectivity63 and the Network Analysis64 
toolboxes, as well as in-house functions in MATLAB.
Statistics. Statistical tests for the clinical and demographic variables were implemented in SPSS (Statistical 
Package for the Social Sciences v22, IBM) and these are defined in Table 1. All EEG scores of variability, standard 
deviations and DFV, were log-transformed to approximate their distribution to a Gaussian. Differences in DF and 
DFV were investigated with a one-way ANOVA for the four groups and post-hoc unpaired t-tests for between 
group comparisons. Significance of MST measures was assessed in three steps. First, significant differences were 
investigated with two-way four-group ANOVAs for each MST measure as dependant variable and the following 
factors as independent variables: group (HC, AD, DLB, and PDD), frequency (delta, theta, high-theta, alpha, 
beta, and DF) and their interaction (group and frequency). Null hypotheses were rejected if either the diagnosis 
or the interaction effects were significant at a p-value < 0.0025 thus accounting for the 20 MST measures assessed, 
i.e. Bonferroni correction. Secondly, for the significant two-way ANOVAs, post-hoc multiple one-way ANOVAs 
at each frequency band were evaluated and their significance was again Bonferroni corrected by the number of 
post-hoc tests, leading to an uncorrected p-value threshold of <0.0007 (since 12 two-way ANOVAs survived the 
first stage of tests). Finally, group differences were assessed with multiple unpaired t-tests. For this latter step we 
were interested in three exploratory diagnostic scenarios of significant difference: AD vs DLB, DLB vs PDD and 
HC vs both AD and DLB (AD + DLB). Notice that differences in DF is a hypothesized test based on previous 
literature and as such the post-hoc tests of the one-way ANOVA are uncorrected, while the two-way four-group 
ANOVA tests for the multiple network measures are corrected for multiple tests or comparisons.
In order to assess relations of network measures with the clinical variables in our dementia patients, we imple-
mented a multiple linear regression for the three dementia groups with clinical variable as the dependant variable 
and the network measure as the independent variable. Additionally, we included two dichotomous regressors for 
the DLB and PDD groups, in order to account for the group effects. The AD group was left as the reference group 
for being the largest group in our investigation. Before regression analysis, all measures of variability including 
DFV were log-transformed to approximate their distribution to Gaussian. The regression was considered signifi-
cant if the first coefficient of the model (β1 for the network measure) was significant at a p-value < 0.05. The effect 
of Levodopa medication (LEDD) was assessed with multiple regression for the DLB and PDD groups, with one 
dichotomous variable to account for the group effect.
To assess the diagnostic accuracy of the studied measures in the three diagnostic scenarios, we implemented a 
logistic regression classification (Matlab functions glmfit.m and glmval.m); sensitivity, specificity and area under 
the curve (AUC) were computed for each scenario; confidence intervals were estimated by statistical bootstrap-
ping with 5000 iterations (Matlab function perfcurve.m). For the DLB vs AD case, scores from the PLI mean, 
PLI leaf mean, PLI root mean in the high-theta band, PLI mean, PLI root mean, PLI height mean in the beta 
band, DF and DFV were used as regressors. For DLB vs PDD, scores from the PLI mean, PLI root mean and PLI 
height mean in the alpha band were used in the logistic regression. The HC vs AD + DLB diagnostic scenario 
used twelve network features as regressors which also showed significant differences, Supplementary Table S6. 
Diagnostic classification of HC vs PDD was not implemented. In order to find the most significant discriminants 
for the three diagnostic scenarios a stepwise multiple linear regression was implemented.
Network display and layout. In order to observe network topology characteristics within our studied 
groups, participants at the group median for the leaf ratio mean in the alpha band were selected as representative 
of each group. Leaf ratio mean scores were chosen for being consistently higher in the HCs compared with the 
dementia groups but not between the dementias. For each selected participant, the 49 PLI connectivity matrices 
were averaged. From the mean connectivity matrix, the MST was extracted and displayed using a forced-directed 
graph layout64, which facilitates graph visualisation by minimising edge crossings. This procedure was also 
repeated for the DF band for the same participants.
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